Page 8 - Daniel Acker Bloomberg News Today

The season to be jolly is hitting a sour note this year, affecting both baking and consumer trends.

“Controligarchs” reveals the dystopian systems and tactics that Klaus Schwab’s World Economic Forum (WEF) has used to achieve global political power and social control.

The new book "Controligarchs" explores Bill Gates’s complicated relationship with pedophile financier Jeffrey Epstein and sheds new light on the mutual associations and interests these two men shared.

Buffett has long said such trading would be a conflict of interest, and Berkshire policies prohibit it. But confidential records show that, on at least three occasions, he sold millions of dollars of shares in stocks that Berkshire was trading.

The Eli Lilly drug, which will be marketed as an obesity treatment under the name Zepbound, is already sold as a diabetes treatment named Mounjaro.

The Eli Lilly drug, which will be marketed as an obesity treatment under the name Zepbound, is already sold as a diabetes treatment named Mounjaro.

D.R. Horton reports earnings and revenue ahead of analysts' expectations and raises its quarterly dividend to 30 cents a share.

It’s time to squash the rumors for good.

The big residential builder reports earnings on Tuesday.

Cosmetics company Estée Lauder cut its fiscal-year outlook as headwinds in China are expected to persist.